mRNA Vaccines and mRNA Drugs Market, Size, Share 2024

mRNA Vaccines and mRNA Drugs Market, Global Outlook and Forecast 2023-2029

Report ID

35991

Publisher

Market Monitor Global

Published Date

17-Oct

Delivery Format

PDF

No of Report Page

118

Editor's Rating

Report Details

This research report provides a comprehensive analysis of the mRNA Vaccines and mRNA Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global mRNA Vaccines and mRNA Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of mRNA Vaccines and mRNA Drugs, challenges faced by the industry, and potential opportunities for market players.

The global mRNA Vaccines and mRNA Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The mRNA Vaccines and mRNA Drugs market presents opportunities for various stakeholders, including Infectious Disease, Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in mRNA Vaccines and mRNA Drugs market. Additionally, the growing consumer demand present avenues for market expansion.

The global mRNA Vaccines and mRNA Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Key Features:
The research report on the mRNA Vaccines and mRNA Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.

Executive Summary: The report provides overview of the key findings, market trends, and major insights of the mRNA Vaccines and mRNA Drugs market.

Market Overview: The report provides a comprehensive overview of the mRNA Vaccines and mRNA Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Vaccine, API), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.

Market Dynamics: The report analyses the market dynamics driving the growth and development of the mRNA Vaccines and mRNA Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the mRNA Vaccines and mRNA Drugs market's trajectory.

Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the mRNA Vaccines and mRNA Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.

Market Segmentation and Forecast: The report segment the mRNA Vaccines and mRNA Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.

Technological Trends: The report should highlight the key technological trends shaping the mRNA Vaccines and mRNA Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.

Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the mRNA Vaccines and mRNA Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.

Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for mRNA Vaccines and mRNA Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.

Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the mRNA Vaccines and mRNA Drugs market.

Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.

Market Segmentation
mRNA Vaccines and mRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type

Vaccine
API

Market segment by Application

Infectious Disease
Cancer

By Region

Global mRNA Vaccines and mRNA Drugs Market Segment Percentages, By Region and Country, 2022 (%)

North America

US
Canada
Mexico

Europe

Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe

Asia

China
Japan
South Korea
Southeast Asia
India
Rest of Asia

South America

Brazil
Argentina
Rest of South America

Middle East & Africa

Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Major players covered

Thermo Fisher
Merck
Qiagen N.V.
CureVac
In-Cell-Art
eTheRNA
Takara Bio Inc.
Sangamo Therapeutics
Roche CustomBiotech
BioNTech
Tiba Biotechnology
TriLink Bio Technologies
Argos Therapeutics
Moderna Therapeutics
NEB
Ethris
Aldevron
Promega
Translate Bio

Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Vaccines and mRNA Drugs, market overview.

Chapter 2: Global mRNA Vaccines and mRNA Drugs market size in revenue and volume.

Chapter 3: Detailed analysis of mRNA Vaccines and mRNA Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of mRNA Vaccines and mRNA Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global mRNA Vaccines and mRNA Drugs capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Table Of Content

1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines and mRNA Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines and mRNA Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines and mRNA Drugs Overall Market Size
2.1 Global mRNA Vaccines and mRNA Drugs Market Size: 2022 VS 2029
2.2 Global mRNA Vaccines and mRNA Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global mRNA Vaccines and mRNA Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top mRNA Vaccines and mRNA Drugs Players in Global Market
3.2 Top Global mRNA Vaccines and mRNA Drugs Companies Ranked by Revenue
3.3 Global mRNA Vaccines and mRNA Drugs Revenue by Companies
3.4 Global mRNA Vaccines and mRNA Drugs Sales by Companies
3.5 Global mRNA Vaccines and mRNA Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 mRNA Vaccines and mRNA Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers mRNA Vaccines and mRNA Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Players in Global Market
3.8.1 List of Global Tier 1 mRNA Vaccines and mRNA Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccines and mRNA Drugs Market Size Markets, 2022 & 2029
4.1.2 Vaccine
4.1.3 API
4.2 By Type - Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
4.2.3 By Type - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
4.3.1 By Type - Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
4.3.2 By Type - Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
4.3.3 By Type - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
4.4 By Type - Global mRNA Vaccines and mRNA Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccines and mRNA Drugs Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application - Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
5.2.3 By Application - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
5.3.1 By Application - Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
5.3.2 By Application - Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
5.3.3 By Application - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
5.4 By Application - Global mRNA Vaccines and mRNA Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global mRNA Vaccines and mRNA Drugs Market Size, 2022 & 2029
6.2 By Region - Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
6.2.3 By Region - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
6.3.1 By Region - Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
6.3.2 By Region - Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
6.3.3 By Region - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.4.2 By Country - North America mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.4.3 US mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.4.4 Canada mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.4.5 Mexico mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.5.2 By Country - Europe mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.5.3 Germany mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.4 France mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.5 U.K. mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.6 Italy mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.7 Russia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.8 Nordic Countries mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.9 Benelux mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.6.2 By Region - Asia mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.6.3 China mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.4 Japan mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.5 South Korea mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.6 Southeast Asia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.7 India mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.7.2 By Country - South America mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.7.3 Brazil mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.7.4 Argentina mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.8.3 Turkey mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.4 Israel mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.6 UAE mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Major Product Offerings
7.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck mRNA Vaccines and mRNA Drugs Major Product Offerings
7.2.4 Merck mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Company Summary
7.3.2 Qiagen N.V. Business Overview
7.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Major Product Offerings
7.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Qiagen N.V. Key News & Latest Developments
7.4 CureVac
7.4.1 CureVac Company Summary
7.4.2 CureVac Business Overview
7.4.3 CureVac mRNA Vaccines and mRNA Drugs Major Product Offerings
7.4.4 CureVac mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.4.5 CureVac Key News & Latest Developments
7.5 In-Cell-Art
7.5.1 In-Cell-Art Company Summary
7.5.2 In-Cell-Art Business Overview
7.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Major Product Offerings
7.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.5.5 In-Cell-Art Key News & Latest Developments
7.6 eTheRNA
7.6.1 eTheRNA Company Summary
7.6.2 eTheRNA Business Overview
7.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Major Product Offerings
7.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.6.5 eTheRNA Key News & Latest Developments
7.7 Takara Bio Inc.
7.7.1 Takara Bio Inc. Company Summary
7.7.2 Takara Bio Inc. Business Overview
7.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Major Product Offerings
7.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Takara Bio Inc. Key News & Latest Developments
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Company Summary
7.8.2 Sangamo Therapeutics Business Overview
7.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sangamo Therapeutics Key News & Latest Developments
7.9 Roche CustomBiotech
7.9.1 Roche CustomBiotech Company Summary
7.9.2 Roche CustomBiotech Business Overview
7.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Major Product Offerings
7.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Roche CustomBiotech Key News & Latest Developments
7.10 BioNTech
7.10.1 BioNTech Company Summary
7.10.2 BioNTech Business Overview
7.10.3 BioNTech mRNA Vaccines and mRNA Drugs Major Product Offerings
7.10.4 BioNTech mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.10.5 BioNTech Key News & Latest Developments
7.11 Tiba Biotechnology
7.11.1 Tiba Biotechnology Company Summary
7.11.2 Tiba Biotechnology Business Overview
7.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Major Product Offerings
7.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Tiba Biotechnology Key News & Latest Developments
7.12 TriLink Bio Technologies
7.12.1 TriLink Bio Technologies Company Summary
7.12.2 TriLink Bio Technologies Business Overview
7.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Major Product Offerings
7.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.12.5 TriLink Bio Technologies Key News & Latest Developments
7.13 Argos Therapeutics
7.13.1 Argos Therapeutics Company Summary
7.13.2 Argos Therapeutics Business Overview
7.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Argos Therapeutics Key News & Latest Developments
7.14 Moderna Therapeutics
7.14.1 Moderna Therapeutics Company Summary
7.14.2 Moderna Therapeutics Business Overview
7.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Moderna Therapeutics Key News & Latest Developments
7.15 NEB
7.15.1 NEB Company Summary
7.15.2 NEB Business Overview
7.15.3 NEB mRNA Vaccines and mRNA Drugs Major Product Offerings
7.15.4 NEB mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.15.5 NEB Key News & Latest Developments
7.16 Ethris
7.16.1 Ethris Company Summary
7.16.2 Ethris Business Overview
7.16.3 Ethris mRNA Vaccines and mRNA Drugs Major Product Offerings
7.16.4 Ethris mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Ethris Key News & Latest Developments
7.17 Aldevron
7.17.1 Aldevron Company Summary
7.17.2 Aldevron Business Overview
7.17.3 Aldevron mRNA Vaccines and mRNA Drugs Major Product Offerings
7.17.4 Aldevron mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Aldevron Key News & Latest Developments
7.18 Promega
7.18.1 Promega Company Summary
7.18.2 Promega Business Overview
7.18.3 Promega mRNA Vaccines and mRNA Drugs Major Product Offerings
7.18.4 Promega mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Promega Key News & Latest Developments
7.19 Translate Bio
7.19.1 Translate Bio Company Summary
7.19.2 Translate Bio Business Overview
7.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Major Product Offerings
7.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Translate Bio Key News & Latest Developments
8 Global mRNA Vaccines and mRNA Drugs Production Capacity, Analysis
8.1 Global mRNA Vaccines and mRNA Drugs Production Capacity, 2018-2029
8.2 mRNA Vaccines and mRNA Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global mRNA Vaccines and mRNA Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 mRNA Vaccines and mRNA Drugs Supply Chain Analysis
10.1 mRNA Vaccines and mRNA Drugs Industry Value Chain
10.2 mRNA Vaccines and mRNA Drugs Upstream Market
10.3 mRNA Vaccines and mRNA Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 mRNA Vaccines and mRNA Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

Inquiry Before Buying
Inquiry Before Buying

Your personal details will remain secure and confidential - Privacy Policy
WHY CHOOSE US

Easy Access and Express Report Delivery Service

Discover Business Growth Opportunities

More than 10 Years Experience Employee Support

In-depth and Comprehensive Analysis

100+ Client Queries Handled Everyday
Request Sample
Request For Sample

Your personal details will remain secure and confidential - Privacy Policy
WHY CHOOSE US

Easy Access and Express Report Delivery Service

Discover Business Growth Opportunities

More than 10 Years Experience Employee Support

In-depth and Comprehensive Analysis

100+ Client Queries Handled Everyday

Our Trusted Clients

This report aims to provide a comprehensive presentation of the global market for Copper Tungsten, [...]

Inquiry Before Buying

WHY CHOOSE US

Request For Sample

WHY CHOOSE US